Skip to content

American Well AMWL Equity in earnings (losses) of equity method investees

Equity in earnings (losses) of equity method investees at other companies

DocGo logo
DocGoDCGO
Humana logo
HumanaHUM
Evolent Health, Inc. logo
Evolent Health, Inc.EVH
HealthStream logo
HealthStreamHSTM

Other financials

Income statement

See full
Revenue$54.9M-17.9%
Gross profit$28.0M-20.7%
Operating income-$17.4M+42.7%
Net income-$10.9M+41.8%
EPS (diluted)-$0.66+44.5%

Balance sheet

See full
Cash & equivalents$179.2M-19.4%
Total debt$4.0M-45.7%
Total equity$227.3M-22.7%
Total assets$326.0M-22.3%

Cash flow

See full
Operating cash flow-$983.0K+96.1%
CapEx$5.0K-44.4%
Free cash flow-$988.0K+96.1%

Valuation

See full
Market cap$154.55M+29.3%
Enterprise value-$20.69M-77.8%
P/S0.7×+0.2×

Profitability

See full
Gross margin52.9%+8.6pp
Operating margin-38.9%-11.3pp
Net margin-37%-10.1pp
FCF margin-17.6%-5.9pp

Returns & leverage

See full
Return on equity-33.7%-6.4pp
Debt / equity0.0×
Current ratio3.1×+0.2×

Where this comes from

Reported directly by American Well in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromEquityMethodInvestments.

The official record: American Well’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about American Well's equity in earnings (losses) of equity method investees.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is American Well's equity in earnings (losses) of equity method investees?
American Well (AMWL) reported equity in earnings (losses) of equity method investees of $0 in Q1 2026.
How has American Well's equity in earnings (losses) of equity method investees changed year-over-year?
American Well's equity in earnings (losses) of equity method investees increased by 100.0% year-over-year, from -$778K to $0.
What is the long-term trend for American Well's equity in earnings (losses) of equity method investees?
Over 4 years (2021 to 2025), American Well's equity in earnings (losses) of equity method investees has grown at a -14.2% compound annual growth rate (CAGR), from -$3.13M to -$1.7M.